evidence: In patients with a high disease activity at baseline, the clinical efficacy of abatacept was similar to adalimumab and tocilizumab.
intervention: abatacept
comparator: tocilizumab
outcome: treatment of RA (Rheumatoid arthritis) patients with a high disease activity at baseline